Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Söderlund, R. Essen, J. Haapasaari, U. Kiistala, O. Kiviluoto, K. Hedman (1997)
Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathyThe Lancet, 349
R. Petty, T. Southwood, J. Baum, E. Bhettay, D. Glass, P. Manners, J. Maldonado-Cocco, M. Suarez‐Almazor, J. Orozco‐Alcala, A. Prieur (1998)
Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997.The Journal of rheumatology, 25 10
K. Zakrzewska, A. Azzi, E. Biasi, P. Radossi, R. Santis, P. Davoli, G. Tagariello (2001)
Persistence of parvovirus B19 DNA in synovium of patients with haemophilic arthritisJournal of Medical Virology, 65
S. Dorsch, G. Liebisch, B. Kaufmann, P. Landenberg, J. Hoffmann, W. Drobnik, S. Modrow (2002)
The VP1 Unique Region of Parvovirus B19 and Its Constituent Phospholipase A2-Like ActivityJournal of Virology, 76
J. Pont, E. Puchhammer-Stöckl, A. Chott, T. Popow-Kraupp, H. Kienzer, G. Postner, N. Honetz (1992)
Recurrent granulocytic aplasia as clinical presentation of a persistent parvovirus B19 infectionBritish Journal of Haematology, 80
A. Mimori, Y. Misaki, T. Hachiya, K. Ito, S. Kano (2004)
Prevalence of antihuman parvovirus B19 IgG antibodies in patients with refractory rheumatoid arthritis and polyarticular juvenile rheumatoid arthritisRheumatology International, 14
K. Schowengerdt, J. Ni, S. Denfield, R. Gajarski, N. Bowles, G. Rosenthal, D. Kearney, J. Price, B. Rogers, Gail Schauer, R. Chinnock, J. Towbin (1997)
Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction.Circulation, 96 10
J. Kerr, V. Cunniffe (2000)
Antibodies to parvovirus B19 non-structural protein are associated with chronic but not acute arthritis following B19 infection.Rheumatology, 39 8
A. Servant, S. Laperche, F. Lallemand, V. Marinho, G. Maur, J. Meritet, A. Garbarg‐Chenon (2002)
Genetic Diversity within Human Erythroviruses: Identification of Three GenotypesJournal of Virology, 76
A. Eis-Hübinger, U. Reber, Thair Abdul-Nour, U. Glatzel, H. Lauschke, U. Pütz (2001)
Evidence for persistence of parvovirus B19 DNA in livers of adultsJournal of Medical Virology, 65
K. Ozawa, N. Young (1987)
Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell culturesJournal of Virology, 61
T. Török (1997)
Unusual Clinical Manifestations Reported in Patients with Parvovirus B19 Infection, 20
Cherry Jd (1999)
Parvovirus infections in children and adults.Advances in Pediatrics, 46
Z. Zádori, J. Szelei, M. Lacoste, Y. Li, S. Gariepy, P. Raymond, M. Allaire, I. Nabi, P. Tijssen (2001)
A viral phospholipase A2 is required for parvovirus infectivity.Developmental cell, 1 2
H. Stahl, B. Seidl, B. Hubner, S. Altrichter, R. Pfeiffer, B. Pustowoit, U. Liebert, J. Hofmann, G. Salis-Soglio, F. Emmrich (2000)
High Incidence of Parvovirus B19 DNA in Synovial Tissue of Patients with Undifferentiated Mono- and OligoarthritisClinical Rheumatology, 19
Kerr Kerr, Mattey Mattey, Thomson Thomson, Poulton Poulton, Ollier Ollier (2002)
Association of acute human parvovirus B19 infection with human leukocyte antigen class I and II allelesJ Infect Dis, 186
A. Knöll, F. Louwen, B. Kochanowski, A. Plentz, J. Stüssel, K. Beckenlehner, W. Jilg, S. Modrow (2002)
Parvovirus B19 infection in pregnancy: Quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR)Journal of Medical Virology, 67
K. Brown (1997)
Human Parvovirus B19 Epidemiology and Clinical Manifestations, 20
Saal Jg, M. Steidle, Hermann Einsele, C. Müller, P. Fritz, J. Zacher (2004)
Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritisRheumatology International, 12
S. Moffatt, N. Yaegashi, K. Tada, N. Tanaka, K. Sugamura (1998)
Human Parvovirus B19 Nonstructural (NS1) Protein Induces Apoptosis in Erythroid Lineage CellsJournal of Virology, 72
P. Cassinotti, G. Siegl, B. Michel, P. Brühlmann (1998)
Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown originJournal of Medical Virology, 56
A. Hemauer, A. Gigler, K. Searle, K. Beckenlehner, U. Raab, K. Broliden, H. Wolf, G. Enders, S. Modrow (2000)
Seroprevalence of parvovirus B19 NS1‐specific IgG in B19‐infected and uninfected individuals and in infected pregnant womenJournal of Medical Virology, 60
G. Kurtzman, B. Cohen, A. Field, R. Oseas, R. Blaese, N. Young (1989)
Immune response to B19 parvovirus and an antibody defect in persistent viral infection.The Journal of clinical investigation, 84 4
A. Hemauer, A. Poblotzki, A. Gigler, P. Cassinotti, G. Siegl, Hans Wolf, S. Modrow (1996)
Sequence variability among different parvovirus B19 isolates.The Journal of general virology, 77 ( Pt 8)
U. Raab, B. Bauer, A. Gigler, K. Beckenlehner, H. Wolf, S. Modrow (2001)
Cellular transcription factors that interact with p6 promoter elements of parvovirus B19.The Journal of general virology, 82 Pt 6
F. Arnett, S. Edworthy, D. Bloch, D. McShane, J. Fries, N. Cooper, L. Healey, S. Kaplan, M. Liang, H. Luthra, T. Medsger, D. Mitchell, D. Neustadt, R. Pinals, J. Schaller, J. Sharp, R. Wilder, G. Hunder (1988)
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.Arthritis and rheumatism, 31 3
Petty Petty, Southwood Southwood, Baum Baum, Bheattay Bheattay, Glass Glass, Manners Manners (1998)
Revision of the proposed classification criteria for juvenile idiopathic arthritisJ Rheumatol, 25
P. Cassinotti, G. Siegl (2000)
Quantitative Evidence for Persistence of Human Parvovirus B19 DNA in an Immunocompetent IndividualEuropean Journal of Clinical Microbiology and Infectious Diseases, 19
B. Kaufmann, A. Simpson, M. Rossmann (2004)
The structure of human parvovirus B19.Proceedings of the National Academy of Sciences of the United States of America, 101 32
H. Lehmann, L. Kühner, K. Beckenlehner, E. Müller-Godeffroy, K. Heide, R. Küster, S. Modrow (2002)
Chronic human parvovirus B19 infection in rheumatic disease of childhood and adolescence.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 25 2
G. Nigro, V. Bastianon, V. Colloridi, F. Ventriglia, P. Gallo, G. d’Amati, W. Koch, S. Adler (2000)
Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 31 1
F. Arnett (1990)
Revised criteria for the classification of rheumatoid arthritis.Orthopedic nursing, 9 2
G. Kurtzman, N. Frickhofen, J. Kimball, D. Jenkins, A. Nienhuis, N. Young (1989)
Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy.The New England journal of medicine, 321 8
J. Nocton, L. Miller, L. Tucker, J. Schaller (1993)
Human parvovirus B19-associatedarthritis in childrenThe Journal of Pediatrics, 122
C. Prowse, C. Ludlam, P. Yap (1997)
Human Parvovirus B19 and Blood ProductsVox Sanguinis, 72
N. Ray, D. Nieva, E. Seftor, Z. Khalkhali‐Ellis, S. Naides, S. Naides (2001)
Induction of an invasive phenotype by human parvovirus B19 in normal human synovial fibroblasts.Arthritis and rheumatism, 44 7
G. Kurtzman, K. Ozawa, B. Cohen, G. Hanson, R. Oseas, N. Young (1987)
Chronic bone marrow failure due to persistent B19 parvovirus infection.The New England journal of medicine, 317 5
R. Gareus, A. Gigler, A. Hemauer, M. Leruez-Ville, F. Morinet, H. Wolf, S. Modrow (1998)
Characterization of cis-Acting and NS1 Protein-Responsive Elements in the p6 Promoter of Parvovirus B19Journal of Virology, 72
P. Cassinotti, G. Burtonboy, M. Fopp, G. Siegl (1997)
Evidence for persistence of human parvovirus B19 DNA in bone marrowJournal of Medical Virology, 53
A. Hemauer, S. Modrow, J. Georgi, K. Helmke, P. Vaith, B. Lang, J. Schölmerich, R. Straub (1999)
There is no association between polymyalgia rheumatica and acute parvovirus B19 infectionAnnals of the Rheumatic Diseases, 58
J. Kerr, D. Mattey, W. Thomson, K. Poulton, W. Ollier (2002)
Association of symptomatic acute human parvovirus B19 infection with human leukocyte antigen class I and II alleles.The Journal of infectious diseases, 186 4
J. Jordan, B. Tiangco, J. Kiss, W. Koch (1998)
Human Parvovirus B19: Prevalence of Viral DNA in Volunteer Blood Donors and Clinical Outcomes of Transfusion RecipientsVox Sanguinis, 75
H. Stahl, B. Hubner, B. Seidl, U. Liebert, Ineke Heijden, B. Wilbrink, M. Kraan, F. Emmrich, P. Tak (2000)
Detection of multiple viral DNA species in synovial tissue and fluid of patients with early arthritisAnnals of the Rheumatic Diseases, 59
C. Wakamatsu, F. Takakura, E. Kojima, Y. Kiriyama, N. Goto, K. Matsumoto, M. Oyama, Hiroyuki Sato, Kazuo Okochi, Yoshiaki Maeda (1999)
Screening of Blood Donors for Human Parvovirus B19 and Characterization of the ResultsVox Sanguinis, 76
K. Hokynar, J. Brunstein, M. Söderlund-Venermo, O. Kiviluoto, E. Partio, Y. Konttinen, K. Hedman (2000)
Integrity and full coding sequence of B19 virus DNA persisting in human synovial tissue.The Journal of general virology, 81 Pt 4
A. Poblotzki, A. Hemauer, A. Gigler, E. Puchhammer-Stöckl, F. Heinz, J. Pont, K. Laczika, H. Wolf, S. Modrow (1995)
Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: implications for pathogenesis.The Journal of infectious diseases, 172 5
K. Ozawa, J. Ayub, N. Young (1988)
Functional mapping of the genome of the B19 (human) parvovirus by in vitro translation after negative hybrid selectionJournal of Virology, 62
Objective To find further evidence of the association of parvovirus B19 infection with juvenile rheumatic diseases, and to get new insights into the immunopathogenesis of these diseases. Methods Paired serum and synovial fluid samples from 74 children with rheumatic disease were analyzed with respect to their content of viral DNA and antibodies directed against the B19 viral proteins VP1, VP2, and NS1. Control sera from 124 children with noninflammatory bone diseases or growth retardation were also analyzed. The sequence of the viral DNA, amplified by polymerase chain reaction (PCR), was determined. IgG‐complexed virus was isolated from sera and synovial fluid by adsorption to protein A beads. The amount of free virus versus immunocomplexed virus particles was determined by quantification of the viral genomes by quantitative PCR. Results Twenty‐six of the 74 patients (35%) had detectable amounts of parvovirus B19 DNA in the serum (n = 22 (30%)) and/or the synovial fluid (n = 16 (22%)), whereas only 9 of the 124 control sera (7%) were positive for the viral DNA (P < 0.0001). Forty‐six patients (62%) had serum IgG against the structural proteins, indicating past infection with B19. NS1‐specific antibodies were detected in sera from 29 patients (39%) and 27 controls (22%) (P < 0.001). In addition, 3 patients (4%) showed VP2‐specific IgM. In 15 patients, viral DNA could be repeatedly detected in followup samples of serum and synovial fluid. Sequencing revealed low‐degree nucleotide variations that are in the range of genotype 1 of parvovirus B19. Immunocomplexed virus was present in varying amounts, both in the sera and in the synovial fluid samples. Conclusion Parvovirus B19 is frequently found in serum or synovial fluid of children with rheumatism. The rate of persistent B19 infection in these patients is significantly higher than in age‐matched controls.
Arthritis & Rheumatism – Wiley
Published: Jun 1, 2003
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.